BI 425809

BI-425809 · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

20 regulatory and trial events tracked for BI 425809, covering 2020-11-06 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Healthy People to Test How BI 425809 is Taken up in the Body When Taken With or Without Food [Phase 1]